Instrument dashboard

Edwards Lifesciences Corp (EW)

NYSE · US

EW · Market chart

Loading chart…

Latest Pine script: 2026-11-18

Market structure

PRICE LEVEL INTELLIGENCE

Reference close · 2026-11-20
LEVEL / SOURCEPRICE LEVELPRICE
Rising Structural SupportTECHNICAL · Anchors: 2025-04-09 at 65.94 and 2026-02-11 at 74.66. x represents elapsed calendar days since 2025-04-09. The positive slope connects the two historical swing lows and defines the primary rising structural support trajectory. The geometry is fixed and projected forward.
—
ATR 82.53–89.09TECHNICAL · Boundaries correspond to the 2026-07-24 significant control bar low of 82.53 and high of 89.09. Its true range was approximately 2.55 times ATR(14), satisfying the 2x ATR criterion. The region is currently Support because the latest close of 105.43 is above its upper boundary.
82.53 – 89.09
ATR 87.90–95.75TECHNICAL · Boundaries correspond to the 2026-11-02 significant control bar low of 87.90 and high of 95.75. Its true range was approximately 3.01 times ATR(14), satisfying the 2x ATR criterion. The region is currently Support because the latest close of 105.43 is above its upper boundary.
87.90 – 95.75
ATR 105.66–111.96TECHNICAL · Boundaries correspond to the 2021-10-04 significant control bar low of 105.66 and high of 111.96. Its true range was approximately 2.27 times ATR(14), satisfying the 2x ATR criterion. The boundaries also correspond to the historical control-bar extremes. The region is currently Resistance because the latest close of 105.43 is below its lower boundary.
105.66 – 111.96
ATR 110.00–116.84TECHNICAL · Boundaries correspond to the 2021-10-28 significant control bar low of 110.00 and high of 116.84. Its true range was approximately 2.48 times ATR(14), satisfying the 2x ATR criterion. The boundaries also correspond to historical control-bar extremes. The region is currently Resistance because the latest close of 105.43 is below its lower boundary.
110.00 – 116.84
Analyst 12-month low targetANALYST · Lowest analyst 12-month price target
84.00
Ascending Triangle ResistanceTECHNICAL · Anchored to the historical high of 96.12 on 2024-03-28. Represented by a fixed horizontal structural line. Support when close >= 96.12 and resistance when close < 96.12.
96.12
S3 102.31TECHNICAL · Calculated from the 2026-11-16 Traditional daily pivot using L - 2(H - P) = 102.3067. Support when close >= 102.31.
102.31
S2 103.62TECHNICAL · Calculated from the 2026-11-16 Traditional daily pivot using P - H + L = 103.6233. Support when close >= 103.62.
103.62
S1 105.37TECHNICAL · Calculated from the 2026-11-16 Traditional daily pivot using 2P - H = 105.3667. Support when close >= 105.37.
105.37
P 106.68TECHNICAL · Calculated using the completed 2026-11-16 trading session: (108.00 + 104.94 + 107.11) / 3 = 106.6833. Traditional daily pivot. Resistance at the supplied latest close of 105.43.
106.68
R1 108.43TECHNICAL · Calculated from the 2026-11-16 Traditional daily pivot using 2P - L = 108.4267. Resistance when close < 108.43.
108.43
R2 109.74TECHNICAL · Calculated from the 2026-11-16 Traditional daily pivot using P + H - L = 109.7433. Resistance when close < 109.74.
109.74
R3 111.49TECHNICAL · Calculated from the 2026-11-16 Traditional daily pivot using H + 2(P - L) = 111.4867. Resistance when close < 111.49.
111.49
Analyst 12-month median targetANALYST · Median analyst 12-month price target
115.00
Analyst 12-month high targetANALYST · Highest analyst 12-month price target
126.00
GEX put wall · 2026-12-18GEX · Options positioning
97.50
GEX call wall · 2026-12-18GEX · Options positioning
105.00

Sign in to view price levels

Technical, analyst and options-derived levels are available to signed-in members.

Sign in
AI-Ready Research Pack

Download the available financial metrics, calculation methodology and latest technical price levels for EW.

Download research pack
Files included for this instrument:
  • SEC financial metrics calculation guide
  • Financial metrics for the current year
  • Technicals and future GEX levels
Company fundamentals

Financial health

Revenue••••••Profitability••••••Cash flow••••••Capital structure••••••
Available reporting years2026, 2025

Sign in to request beta access

Financial health insights are in a limited beta.

Sign in
Valuation framework

Valuation

Midpoint fair value••••••
Cash Flow DCF••••••
Revenue unit economics••••••
Reporting periods: 3 quarters available

Sign in to request beta access

Valuation tools are in a limited beta.

Sign in